Article

VIDEO: Robert Gabbay, MD, PhD, Speaks About the Cost Implications of Diabetes Management

In this video, Robert Gabbay, MD, PhD, talks about the overall cost implications to diabetes management through behavioral change.

In this video, Robert Gabbay, MD, PhD, speaks about the large toll the cost of diabetes management takes on society, including long-term complications, such as amputations, kidney failure, heart disease, and blindness. Many of these complications can be prevented by effective glucose, cholesterol, and blood pressure control. In addition, effective patient behaviors, such as medication adherence and weight loss/exercise, can help improve outcomes.

He also addresses how economic incentives, such as value-based insurance design, can help promote effective patient behaviors to improve outcomes. Improving outcomes and preventing long-term complications, says Dr. Gabbay, can have a tremendous impact on lowering costs.

This video was taken on June 8, 2012, at the American Diabetes Association's 72nd Scientific Session in Philadelphia, PA.

Related Videos
Bridgette Picou, LVN, ACLPN, The Well Project
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Richard Nowak, MD, MS, Yale School of Medicine
AMCP Recap 2025
Giulio Cossu, MD
Lynae Darbes, PhD
Kimberly Westrich, MA, chief strategy officer at the National Pharmaceutical Council
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center
Jawad Haider Butt, MD, PhD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo